Predictive value of α-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker.

Rabat RaziaFazeel MajeedRehab AminShahid MukhtarKhalid MahmoodTurki AbualaitShahid BashirDeeba Noreen Baig

Published in: PloS one (2023)

Our results imply that measuring α-synuclein levels in both serum and PBMCs could be a valuable method for diagnosing and predicting MS severity, potentially serving as a non-invasive biomarker for the disease.

Keyphrases

multiple sclerosis
peripheral blood
end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
prognostic factors
peritoneal dialysis
ms ms
white matter
patient reported outcomes